Cargando…

A Universal Influenza Virus Vaccine Candidate Tested in a Pig Vaccination-Infection Model in the Presence of Maternal Antibodies

The antigenically conserved hemagglutinin stalk region is a target for universal influenza virus vaccines since antibodies against it can provide broad protection against influenza viruses of different subtypes. We tested a universal influenza virus vaccination regimen based on sequential immunizati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sunwoo, Sun-Young, Schotsaert, Michael, Morozov, Igor, Davis, Anne Sally, Li, Yuhao, Lee, Jinhwa, McDowell, Chester, Meade, Philip, Nachbagauer, Raffael, García-Sastre, Adolfo, Ma, Wenjun, Krammer, Florian, Richt, Juergen A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6161263/ https://www.ncbi.nlm.nih.gov/pubmed/30223475 http://dx.doi.org/10.3390/vaccines6030064

Ejemplares similares

Erratum: Sunwoo, S.-Y. et al. A Universal Influenza Virus Vaccine Candidate Tested in a Pig Vaccination-Infection Model in the Presence of Maternal Antibodies. Vaccines 2018, 6(3), 64
por: Sunwoo, Sun-Young, et al.
Publicado: (2018)

Newcastle disease virus-based H5 influenza vaccine protects chickens from lethal challenge with a highly pathogenic H5N2 avian influenza virus
por: Ma, Jingjiao, et al.
Publicado: (2017)

Author Correction: Newcastle disease virus-based H5 influenza vaccine protects chickens from lethal challenge with a highly pathogenic H5N2 avian influenza virus
por: Ma, Jingjiao, et al.
Publicado: (2018)

A Live-Attenuated Prime, Inactivated Boost Vaccination Strategy with Chimeric Hemagglutinin-Based Universal Influenza Virus Vaccines Provides Protection in Ferrets: A Confirmatory Study
por: Nachbagauer, Raffael, et al.
Publicado: (2018)

Influenza Vaccines: A Moving Interdisciplinary Field
por: Schotsaert, Michael, et al.
Publicado: (2014)

Comparison of Pathogenicity and Transmissibility of Influenza B and D Viruses in Pigs
por: Lee, Jinhwa, et al.
Publicado: (2019)

Stability of SARS-CoV-2 in Biological Fluids of Animals
por: Kwon, Taeyong, et al.
Publicado: (2023)

Complete Genome Sequence of Two Rift Valley Fever Virus Strains Isolated from Outbreaks in Saudi Arabia (2000) and Kenya (2006 to 2007)
por: Shivanna, Vinay, et al.
Publicado: (2016)

The N501Y mutation in SARS-CoV-2 spike leads to morbidity in obese and aged mice and is neutralized by convalescent and post-vaccination human sera
por: Rathnasinghe, Raveen, et al.
Publicado: (2021)

Host immune response–inspired development of the influenza vaccine
por: Choi, Angela, et al.
Publicado: (2020)

Sequential Immunization With Live-Attenuated Chimeric Hemagglutinin-Based Vaccines Confers Heterosubtypic Immunity Against Influenza A Viruses in a Preclinical Ferret Model
por: Liu, Wen-Chun, et al.
Publicado: (2019)

A universal influenza virus vaccine candidate confers protection against pandemic H1N1 infection in preclinical ferret studies
por: Nachbagauer, Raffael, et al.
Publicado: (2017)

Non-sterilizing, Infection-Permissive Vaccination With Inactivated Influenza Virus Vaccine Reshapes Subsequent Virus Infection-Induced Protective Heterosubtypic Immunity From Cellular to Humoral Cross-Reactive Immune Responses
por: Choi, Angela, et al.
Publicado: (2020)

Chimeric Hemagglutinin-Based Live-Attenuated Vaccines Confer Durable Protective Immunity against Influenza A Viruses in a Preclinical Ferret Model
por: Liu, Wen-Chun, et al.
Publicado: (2021)

Immunogenicity and efficacy of Schmallenberg virus envelope glycoprotein subunit vaccines
por: Endalew, Abaineh D., et al.
Publicado: (2019)

A mosaic hemagglutinin-based influenza virus vaccine candidate protects mice from challenge with divergent H3N2 strains
por: Broecker, Felix, et al.
Publicado: (2019)

Introduction of two prolines and removal of the polybasic cleavage site leads to optimal efficacy of a recombinant spike based SARS-CoV-2 vaccine in the mouse model
por: Amanat, Fatima, et al.
Publicado: (2020)

Introduction of Two Prolines and Removal of the Polybasic Cleavage Site Lead to Higher Efficacy of a Recombinant Spike-Based SARS-CoV-2 Vaccine in the Mouse Model
por: Amanat, Fatima, et al.
Publicado: (2021)

A Recombinant Rift Valley Fever Virus Glycoprotein Subunit Vaccine Confers Full Protection against Rift Valley Fever Challenge in Sheep
por: Faburay, Bonto, et al.
Publicado: (2016)

Editorial overview: Emerging viruses: interspecies transmission: Expect the unexpected
por: García-Sastre, Adolfo, et al.
Publicado: (2019)

Evaluating α-galactosylceramide as an adjuvant for live attenuated influenza vaccines in pigs
por: Artiaga, Bianca L., et al.
Publicado: (2022)

TIV Vaccination Modulates Host Responses to Influenza Virus Infection that Correlate with Protection against Bacterial Superinfection
por: Choi, Angela, et al.
Publicado: (2019)

Cryo-electron Microscopy Structures of Chimeric Hemagglutinin Displayed on a Universal Influenza Vaccine Candidate
por: Tran, Erin E. H., et al.
Publicado: (2016)

Ancestral lineage of SARS-CoV-2 is more stable in human biological fluids than Alpha, Beta and Omicron variants of concern
por: Kwon, Taeyong, et al.
Publicado: (2022)

Ancestral Lineage of SARS-CoV-2 Is More Stable in Human Biological Fluids than Alpha, Beta, and Omicron Variants of Concern
por: Kwon, Taeyong, et al.
Publicado: (2023)

Vaccination with a Recombinant H7 Hemagglutinin-Based Influenza Virus Vaccine Induces Broadly Reactive Antibodies in Humans
por: Stadlbauer, Daniel, et al.
Publicado: (2017)

Safety of Recombinant VSV–Ebola Virus Vaccine Vector in Pigs
por: de Wit, Emmie, et al.
Publicado: (2015)

The pig as a mixing vessel for influenza viruses: Human and veterinary implications
por: Ma, Wenjun, et al.
Publicado: (2008)

An immuno-assay to quantify influenza virus hemagglutinin with correctly folded stalk domains in vaccine preparations
por: Rajendran, Madhusudan, et al.
Publicado: (2018)

The E484K mutation in the SARS-CoV-2 spike protein reduces but does not abolish neutralizing activity of human convalescent and post-vaccination sera.
por: Jangra, Sonia, et al.
Publicado: (2021)

Effects of Spike Mutations in SARS-CoV-2 Variants of Concern on Human or Animal ACE2-Mediated Virus Entry and Neutralization
por: Kim, Yunjeong, et al.
Publicado: (2021)

Effects of Spike Mutations in SARS-CoV-2 Variants of Concern on Human or Animal ACE2-Mediated Virus Entry and Neutralization
por: Kim, Yunjeong, et al.
Publicado: (2022)

Hemagglutinin Stalk Antibody Responses Following Trivalent Inactivated Influenza Vaccine Immunization of Pregnant Women and Association With Protection From Influenza Virus Illness
por: Dhar, Nisha, et al.
Publicado: (2020)

Pandemic influenza virus vaccines boost hemagglutinin stalk-specific antibody responses in primed adult and pediatric cohorts
por: Nachbagauer, Raffael, et al.
Publicado: (2019)

DNA-Protein Vaccination Strategy Does Not Protect from Challenge with African Swine Fever Virus Armenia 2007 Strain
por: Sunwoo, Sun-Young, et al.
Publicado: (2019)

Experimental re-infected cats do not transmit SARS-CoV-2
por: Gaudreault, Natasha N., et al.
Publicado: (2021)

Vaccination with Adjuvanted Recombinant Neuraminidase Induces Broad Heterologous, but Not Heterosubtypic, Cross-Protection against Influenza Virus Infection in Mice
por: Wohlbold, Teddy John, et al.
Publicado: (2015)

Moving from Empirical to Rational Vaccine Design in the ‘Omics’ Era
por: Sharma, Mansi, et al.
Publicado: (2019)

A cross-reactive mouse monoclonal antibody against rhinovirus mediates phagocytosis in vitro
por: Behzadi, Mohammad Amin, et al.
Publicado: (2020)

Harnessing Invariant NKT Cells to Improve Influenza Vaccines: A Pig Perspective
por: Yang, Guan, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_o8qpvshlv8na614e0fcqs8ks2i